BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 33455469)

  • 1. Hypoxia-inducible factor (HIF) inhibitors: a patent survey (2016-2020).
    Ban HS; Uto Y; Nakamura H
    Expert Opin Ther Pat; 2021 May; 31(5):387-397. PubMed ID: 33455469
    [No Abstract]   [Full Text] [Related]  

  • 2. Hypoxia-inducible factor (HIF) inhibitors: a patent survey (2011-2015).
    Ban HS; Uto Y; Won M; Nakamura H
    Expert Opin Ther Pat; 2016; 26(3):309-22. PubMed ID: 26882240
    [TBL] [Abstract][Full Text] [Related]  

  • 3. HIF-Dependent Mechanisms of Relationship between Hypoxia Tolerance and Tumor Development.
    Dzhalilova DS; Makarova OV
    Biochemistry (Mosc); 2021 Oct; 86(10):1163-1180. PubMed ID: 34903150
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hypoxia and hypoxia-inducible factors in diabetes and its complications.
    Catrina SB; Zheng X
    Diabetologia; 2021 Apr; 64(4):709-716. PubMed ID: 33496820
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The transcriptional factors HIF-1 and HIF-2 and their novel inhibitors in cancer therapy.
    Albadari N; Deng S; Li W
    Expert Opin Drug Discov; 2019 Jul; 14(7):667-682. PubMed ID: 31070059
    [No Abstract]   [Full Text] [Related]  

  • 6. Current insights and future perspectives of hypoxia-inducible factor-targeted therapy in cancer.
    Ajith TA
    J Basic Clin Physiol Pharmacol; 2018 Dec; 30(1):11-18. PubMed ID: 30260792
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Up-regulation of hypoxia-inducible factors HIF-1alpha and HIF-2alpha under normoxic conditions in renal carcinoma cells by von Hippel-Lindau tumor suppressor gene loss of function.
    Krieg M; Haas R; Brauch H; Acker T; Flamme I; Plate KH
    Oncogene; 2000 Nov; 19(48):5435-43. PubMed ID: 11114720
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Topotecan inhibits vascular endothelial growth factor production and angiogenic activity induced by hypoxia in human neuroblastoma by targeting hypoxia-inducible factor-1alpha and -2alpha.
    Puppo M; Battaglia F; Ottaviano C; Delfino S; Ribatti D; Varesio L; Bosco MC
    Mol Cancer Ther; 2008 Jul; 7(7):1974-84. PubMed ID: 18645007
    [TBL] [Abstract][Full Text] [Related]  

  • 9. HIF in kidney disease and development.
    Gunaratnam L; Bonventre JV
    J Am Soc Nephrol; 2009 Sep; 20(9):1877-87. PubMed ID: 19118148
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Feedback regulators of hypoxia-inducible factors and their role in cancer biology.
    Henze AT; Acker T
    Cell Cycle; 2010 Jul; 9(14):2749-63. PubMed ID: 20603601
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of hypoxia inducible factor-1α downregulates the expression of epithelial to mesenchymal transition early marker proteins without undermining cell survival in hypoxic lens epithelial cells.
    Cammarata PR; Neelam S; Brooks MM
    Mol Vis; 2015; 21():1024-35. PubMed ID: 26392741
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hypoxia-inducible factor inhibitors: a survey of recent patented compounds (2004 - 2010).
    Ban HS; Uto Y; Nakamura H
    Expert Opin Ther Pat; 2011 Feb; 21(2):131-46. PubMed ID: 21210751
    [TBL] [Abstract][Full Text] [Related]  

  • 13. HER2 regulates HIF-2α and drives an increased hypoxic response in breast cancer.
    Jarman EJ; Ward C; Turnbull AK; Martinez-Perez C; Meehan J; Xintaropoulou C; Sims AH; Langdon SP
    Breast Cancer Res; 2019 Jan; 21(1):10. PubMed ID: 30670058
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Multiple receptor tyrosine kinases regulate HIF-1alpha and HIF-2alpha in normoxia and hypoxia in neuroblastoma: implications for antiangiogenic mechanisms of multikinase inhibitors.
    Nilsson MB; Zage PE; Zeng L; Xu L; Cascone T; Wu HK; Saigal B; Zweidler-McKay PA; Heymach JV
    Oncogene; 2010 May; 29(20):2938-49. PubMed ID: 20208561
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hypoxia-mediated drug resistance: novel insights on the functional interaction of HIFs and cell death pathways.
    Rohwer N; Cramer T
    Drug Resist Updat; 2011 Jun; 14(3):191-201. PubMed ID: 21466972
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The balance of beneficial and deleterious effects of hypoxia-inducible factor activation by prolyl hydroxylase inhibitor in rat remnant kidney depends on the timing of administration.
    Yu X; Fang Y; Liu H; Zhu J; Zou J; Xu X; Jiang S; Ding X
    Nephrol Dial Transplant; 2012 Aug; 27(8):3110-9. PubMed ID: 22399494
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hypoxia inducible factor 1α and hypoxia inducible factor 2α play distinct and functionally overlapping roles in oral squamous cell carcinoma.
    Zhu GQ; Tang YL; Li L; Zheng M; Jiang J; Li XY; Chen SX; Liang XH
    Clin Cancer Res; 2010 Oct; 16(19):4732-41. PubMed ID: 20807755
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hypoxia-Inducible Factor Is Critical for Pathogenesis and Regulation of Immune Cell Functions in Rheumatoid Arthritis.
    Guo X; Chen G
    Front Immunol; 2020; 11():1668. PubMed ID: 32849577
    [TBL] [Abstract][Full Text] [Related]  

  • 19. ARNT-dependent HIF-2 transcriptional activity is not sufficient to regulate downstream target genes in neuroblastoma.
    Persson CU; von Stedingk K; Fredlund E; Bexell D; Påhlman S; Wigerup C; Mohlin S
    Exp Cell Res; 2020 Mar; 388(2):111845. PubMed ID: 31945318
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Increased activation of the hypoxia-inducible factor pathway in varicose veins.
    Lim CS; Kiriakidis S; Paleolog EM; Davies AH
    J Vasc Surg; 2012 May; 55(5):1427-39. PubMed ID: 22277691
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.